TickerFactsScreenerDevelopers

TG THERAPEUTICS, INC. (TGTX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $02010: $02011: $9.75M2012: $16.46M2013: $40.49M2014: $55.71M2015: $55.06M2016: $25.03M2017: $56.72M2018: $41.96M2019: $112.64M2020: $553.44M2021: $298.89M2022: $102.30M2023: $92.93M2024: $179.89M2025: $79.15M$79.15M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$79.15M-56.0%
2024$179.89M+93.6%
2023$92.93M-9.2%
2022$102.30M-65.8%
2021$298.89M-46.0%
2020$553.44M+391.3%
2019$112.64M+168.5%
2018$41.96M-26.0%
2017$56.72M+126.6%
2016$25.03M-54.5%
2015$55.06M-1.2%
2014$55.71M+37.6%
2013$40.49M+146.0%
2012$16.46M+68.8%
2011$9.75M—
2010$0—
2009$0—